Drug factory · FDA FEI 3002807507
SGS France
PARC DES CHANTEREINES 4 RUE CDT D'ESTIENNE D'ORVES, Villeneuve-La-Garenne, France
Problems found, fixed voluntarily at FDA's last inspection, Jan 19, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2009: 4 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Metoclopramide | Tests it | Evoke Pharma, Inc. | 72089-307 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 19, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 22, 2018 | No problems found | Drug Quality Assurance | — |
| Sep 17, 2015 | No problems found | Drug Quality Assurance | — |
| Jun 20, 2013 | No problems found | Drug Quality Assurance | — |
| Oct 29, 2009 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.